外分泌胰腺癌病理报告数据集:ICCR 推荐
当前胰腺癌病理报告指南存在差异,导致报告实践不一致和数据可比性不足。国际癌症报告合作组织(ICCR)召集胰腺病理学家、外科医生和肿瘤内科医生组成国际专家组,基于对现有证据的严格审查与讨论,制定了一套核心与非核心数据项,并附注释说明选择理由和临床相关性。经过国际公众咨询后定稿,该数据集含结构化报告指南并发布于 ICCR 网站,旨在促进高质量、标准化的病理报告。
要点
- ICCR 发布首个外分泌胰腺癌切除术标本病理报告国际数据集。
- 数据集含核心与非核心数据项,每项附注释说明临床相关性。
- 采用结构化报告指南,旨在提高报告一致性与数据可比性。
核心结论
- 该首个外分泌胰腺癌国际数据集旨在促进高质量、标准化的病理报告,其广泛采用将提高报告一致性、促进多学科沟通并增强数据可比性,从而有助于改善胰腺癌患者的管理。
研究设计与样本
- ICCR 主导制定,召集包括胰腺病理学家、胰腺外科医生和肿瘤内科医生的国际专家组,基于对当前证据的严格审查与讨论产生核心与非核心数据项。
- 经过国际公众咨询后定稿并批准,数据集含结构化报告指南并发布于 ICCR 网站。
主要发现
- 专家组为每个数据项提供注释,解释将其选为核心或非核心要素的理由及其临床相关性。
- 注释还突出潜在分歧或证据不足的领域,并在此情况下形成共识立场。
关键数值与推荐
- 数据集适用于外分泌胰腺癌(导管腺癌和腺泡细胞癌)切除标本的病理报告。
- 数据项分为核心和非核心两类,核心项为必需报告内容。
临床怎么用
- 病理科医生可采用该结构化报告指南对外分泌胰腺癌切除标本进行标准化报告。
- 标准化报告有助于多学科团队沟通和不同机构间数据比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Current guidelines for pathology reporting on pancreatic cancer differ in certain aspects, resulting in divergent reporting practices and a lack of comparability of data. Here, we report on a new international dataset for pathology reporting on resection specimens with cancer of the exocrine pancreas (ductal adenocarcinoma and acinar cell carcinoma). The dataset was produced under the auspices of the International Collaboration on Cancer Reporting (ICCR), which is a global alliance of major (inter)national pathology and cancer organisations. METHODS AND RESULTS: According to the ICCR's rigorous process for dataset development, an international expert panel consisting of pancreatic pathologists, a pancreatic surgeon and an oncologist produced a set of core and non-core data items based on a critical review and discussion of current evidence. Commentary was provided for each data item to explain the rationale for selecting it as a core or non-core element and its clinical relevance, and to highlight potential areas of disagreement or lack of evidence, in which case a consensus position was formulated. Following international public consultation, the document was finalised and ratified, and the dataset, which includes a synoptic reporting guide, was published on the ICCR website. CONCLUSIONS: This first international dataset for cancer of the exocrine pancreas is intended to promote high-quality, standardised pathology reporting. Its widespread adoption will improve the consistency of reporting, facilitate multidisciplinary communication, and enhance the comparability of data, all of which will help to improve the management of pancreatic cancer patients.
引用
- Verbeke C, Webster F, Brosens L, et al. Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2021. PMID: 34379823. doi:10.1111/his.14540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。